Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2019

Equity [Abstract]

Diluted Earnings per Share

Diluted earnings per share for the three months ended March 31, 2019 and 2018 includes the effects of potential common shares issuable when dilutive, and is as follows:

	Three Months Ended March 31,
	2019		2018
Net income	$	11,130	$	9,853
Weighted average number of common shares outstanding (in '000s)	30,513		30,219
Dilutive effect of restricted stock grants after application of the Treasury Stock Method (in '000s)	181		355
Dilutive shares outstanding	30,694		30,574
Basic earnings per share	$	0.36	$	0.33
Diluted earnings per share	$	0.36	$	0.32

Schedule of Stockholders Equity

The changes in stockholder's equity are as follows:

	Three Months Ended March 31, 2019
	Common Stock			Treasury Stock			Additional Paid In Capital		Retained  Deficit			Accumulated  Other Comp. Loss			Total CVG Stockholders’  Equity
	Shares (in thousands)	Amount
Balance - December 31, 2018	30,513	$	318	$	(10,245	)	$	243,007	$	(70,571	)	$	(47,471	)	$	115,038
Share-based compensation expense	—	—		—			761		—			—			761
Cumulative effect of adoption of Topic 842	—	—		—			—		(72		)	—			(72		)
Total comprehensive income	—	—		—			—		11,130			(206		)	10,924
Balance - March 31, 2019	30,513	$	318	$	(10,245	)	$	243,768	$	(59,513	)	$	(47,677	)	$	126,651

	Three Months Ended March 31, 2018
	Common Stock			Treasury Stock			Additional  Paid In Capital		Retained  Deficit			Accumulated  Other Comp. Loss			Total CVG Stockholders’  Equity
	Shares (in thousands)	Amount
Balance - December 31, 2017	30,219	$	304	$	(9,114	)	$	239,870	$	(115,083	)	$	(41,235	)	$	74,742
Share-based compensation expense	—	—		—			673		—			—			673
Total comprehensive income	—	—		—			—		9,853			1,132			10,985
Balance - March 31, 2018	30,219	$	304	$	(9,114	)	$	240,543	$	(105,230	)	$	(40,103	)	$	86,400